Work

Abstract TMIM-069: PROSPECTIVE CLINICAL VALIDATION OF EX VIVO, PATIENT-SPECIFIC RESPONSE PREDICTION TO FIRST-LINE CHEMOTHERAPY

Year: 2019

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.ovcasymp18-tmim-069

Authors: Stephen Shuford, Jeffrey Elder, Larry Puls, John Weroha, Xiaonan Hou, Valentina Zanfagnin, Alpa Nick, Michael P. Stany, Larry Maxwell, Thomas Conrads, Chris Corless, Anil K. Sood, Matthew Gevaert, Howland E. Crosswell, Teresa M. DesRochers

Institutions: Kiyatec (United States), Prisma Health, Mayo Clinic, Saint Thomas Health, Inova Health System, Oregon Health & Science University, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2993962813

Cites:

Cited by:

Related to: 10